AKRE Akre Focus ETF

Expense Ratio
0.98%
Previous close
$60.31
Est. 12 months change
+17.39%
Projected Price
$70.80

Profitability Metrics

Return on Equity (ROE)
55.93%
Return on Assets (ROA)
11.22%
Return on Invested Capital (ROIC)
31.35%
Weighted Average Cost of Capital (WACC)
8.70%
ROIC - WACC
22.65%
Updated : 2026-11-09 17:26 ET

Valuation Metrics

P/E Ratio
32.76
Forward P/E
20.68
PEG Ratio
2.11
Debt Current Ratio
1.28

Growth & Cash Flow

Gross Margin
62.13%
Operating Margin
14.11%
FCF Margin
30.19%
TTM Revenue Growth
9.36%
Projected 12M EPS Growth
58.43%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MA15.12%
TSX:CSU13.83%
ROP8.19%
TSXV:TOI8.08%
V7.87%
MCO6.91%
BN6.72%
KKR6.47%
CSGP5.34%
NA5.02%

ETF Analysis

Fund Overview

Akre Focus ETF (AKRE) currently reports 18 stock positions (subject to change), placing it in the narrowly constructed range by holdings breadth. The top line-up is MA (15.12%), TSX:CSU (13.83%), ROP (8.19%), with MA as the largest single weight at 15.12%. Together, the top three holdings account for 37.14%, which means the fund's near-term behavior will be closely tied to how its largest positions perform. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 31.35%, WACC is 8.70%, and the economic spread is 22.65%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 55.93% and ROA at 11.22%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a pricing standpoint, the portfolio sits at trailing P/E of 32.76, forward P/E of 20.68, PEG of 2.11. A wide spread between trailing and forward P/E implies the market is embedding substantial earnings improvement into current prices. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio reading of 1.28 suggests the portfolio's holdings carry less short-term financial cushion than the broader market average. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 62.13%, operating margin at 14.11%, and free cash flow margin at 30.19%. The gross margin reading is exceptional — a reliable indicator of competitively advantaged businesses. At this level, operating margins reflect holdings where operational leverage has not yet fully materialized. Free cash flow conversion is exceptional, indicating holdings that are self-funding and cash-generative well above average. Read together, these margin levels suggest a portfolio where earnings durability is present in parts but not consistent across the full holding set.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 9.36% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 17.57%, where the target distribution indicates incremental upside rather than outsized repricing. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.